Serial entrepreneurs are the lifeblood of a vibrant, growing venture capital community, and the Great Lakes Region is home to many successful founders who can translate their past experience into growing new companies in this area. Over the past decade, one Michigan entrepreneur and venture capitalist has proven she has the determination to nurture multiple […]
The Michigan Venture Capital Association’s (MVCA) programs to develop the state’s investment community are helping venture capitalists and their portfolio companies attract and retain top talent.
ProNAi Therapeutics, Inc., a private DNAi cancer drug development company, recently concluded its initial human clinical trial of PNT2258. The company also expanded its management team with the recent appointments of board member and venture capital investor Mina Sooch, MBA, as President and CEO, and Dr. Richard Messmann, MD, as Chief Medical Officer.
ProNAi Therapeutics Inc . has collected $59.5 million after clinical studies showed that its lead drug could help non-Hodgkin’s lymphoma patients who are running out of options.